Pro Share Advisors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Pro Share Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$144.95 - $152.29 $8,407 - $8,832	-58 Reduced 0.72%	7,975 $1.21 Million
Q2 2022 Aug 01, 2022	SELL	$83.14 - $145.99 $317,262 - $557,097	-3,816 Reduced 32.21%	8,033 $1.17 Million
Q1 2022 May 10, 2022	SELL	$110.08 - $142.92 $194,181 - $252,110	-1,764 Reduced 12.96%	11,849 $1.41 Million
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $509,121 - $757,990	5,105 Added 60.0%	13,613 $1.88 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $544,564 - $765,255	-5,509 Reduced 39.3%	8,508 $1.18 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $76,239 - $121,718	1,159 Added 9.01%	14,017 $1.36 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $140,825 - $201,666	2,198 Added 20.62%	12,858 $879,000
Q4 2020 Feb 09, 2021	BUY	$65.07 - $98.24 $309,928 - $467,917	4,763 Added 80.77%	10,660 $914,000
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $30,464 - $40,222	-516 Reduced 8.05%	5,897 $383,000
Q2 2020 Aug 03, 2020	BUY	$29.01 - $74.23 $186,041 - $476,036	6,413 New	6,413 $469,000
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $145,858 - $303,751	-5,302 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$40.86 - $57.65 $216,639 - $305,660	5,302 New	5,302 $289,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.